FDA Enforcement Stance Turned Aggressive Months Before Aug. 6 Initiatives
Executive Summary
FDA began taking a more aggressive enforcement posture toward drug manufacturers in the months leading up to FDA Commissioner Margaret Hamburg's Aug. 6 unveiling of six initiatives to speed up the enforcement process
You may also be interested in...
DDMAC, Soon To Be An Office, Hones In On DTC Advertising
The planned elevation of FDA's Division of Drug Marketing, Advertising and Communications to office status comes amidst an intensified focus on direct-to-consumer advertising.
DDMAC, Soon To Be An Office, Hones In On DTC Advertising
The planned elevation of FDA's Division of Drug Marketing, Advertising and Communications to office status comes amidst an intensified focus on direct-to-consumer advertising.
"The Next Best Way To Block Generics" May Be Novo's Patent Use Code Switch
The generic industry has lined up against Novo Nordisk's maneuver to keep Caraco Pharmaceuticals from getting approval of a generic version of its diabetes drug Prandin